US Archives - Page 119 of 148 - European Medical Journal

Clonazepam Recall Due To Strength Mislabeling

Clonazepam has been recalled due to potential product carton strength mislabeling. Endo Pharmaceuticals (Malvern, Pennsylvania) has issued a voluntary, nationwide recall of a specific lot of Clonazepam Orally Disintegrating Tablets (USP, C-IV).

How Medical AI Bias Risks Patient Care

Bias in medical artificial intelligence (AI) poses a critical threat to equitable patient outcomes, according to recent research.

How Gut Bacteria Impact Tamoxifen Therapy

The response to tamoxifen, a cornerstone drug in preventing breast cancer recurrence, may hinge on an unexpected factor: gut bacteria.

PAH: A Growing Challenge in Aging Populations

Pulmonary arterial hypertension (PAH), a rare yet life-threatening vascular condition, predominantly affects older adults and women, according to new findings from the Global Burden of Disease Study 2021.

Hypervirulent Drug Resistance Emerges from Ukraine War

Pandrug-resistant Klebsiella pneumoniae strains isolated from Ukrainian war victims are raising red flags for healthcare professionals worldwide.

Long-Term Cognitive Impact of Anti-NMDAR Encephalitis

Long-term cognitive and psychosocial challenges faced by individuals recovering from anti-NMDAR encephalitis, despite many regaining independence, have been highlighted in a recent study.

The Key Role of Partners in Rheumatoid Arthritis Care

The way couples manage stress together profoundly impacts outcomes for patients with rheumatoid arthritis (RA), according to a new study.

Targeted IL-23 Therapy: Phase III Psoriasis Study Findings

Results from the Phase III ICONIC-LEAD trial reveal that JNJ-2113 (icotrokinra, Johnson & Johnson, New Jersey), an oral peptide targeting the IL-23 receptor, demonstrated improvements in skin clearance among patients with moderate to severe plaque psoriasis.

Rare Mutated Cells Found in Healthy Breasts

Even healthy breast tissue harbors rare populations of mutated epithelial cells, raising important questions about their role in breast cancer development.

Lung Abnormalities Hidden in Routine Abdominal CTs

In a recent study, researchers found that interstitial lung abnormalities (ILAs), early indicators of interstitial lung disease, were present in 1.7% of routine abdominal and thoracoabdominal CT scans from unselected patients.